These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1772739)

  • 1. Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review.
    Rapoport SI
    Cerebrovasc Brain Metab Rev; 1991; 3(4):297-335. PubMed ID: 1772739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal brain glucose metabolism in Alzheimer's disease, as measured by position emission tomography.
    Rapoport SI; Horwitz B; Grady CL; Haxby JV; DeCarli C; Schapiro MB
    Adv Exp Med Biol; 1991; 291():231-48. PubMed ID: 1927686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: metabolic uncoupling of associative brain regions.
    Rapoport SI; Horwitz B; Haxby JV; Grady CL
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):540-5. PubMed ID: 3491664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of cerebral blood flow and metabolism in patients with senile dementia of the Alzheimer's type and diagnostic evaluation of the dementing illnesses by positron emission tomography].
    Sakamoto S
    Nihon Ika Daigaku Zasshi; 1990 Jun; 57(3):222-34. PubMed ID: 2376611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease.
    Jagust WJ; Eberling JL; Richardson BC; Reed BR; Baker MG; Nordahl TE; Budinger TF
    Brain Res; 1993 Dec; 629(2):189-98. PubMed ID: 8111623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type.
    Haxby JV; Grady CL; Koss E; Horwitz B; Schapiro M; Friedland RP; Rapoport SI
    Neurology; 1988 Dec; 38(12):1853-63. PubMed ID: 3194063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
    DeCarli C; Grady CL; Clark CM; Katz DA; Brady DR; Murphy DG; Haxby JV; Salerno JA; Gillette JA; Gonzalez-Aviles A; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neocortical metabolic abnormalities precede nonmemory cognitive impairments in early dementia of the Alzheimer type: longitudinal confirmation.
    Haxby JV; Grady CL; Friedland RP; Rapoport SI
    J Neural Transm Suppl; 1987; 24():49-53. PubMed ID: 3479529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of regional brain metabolism in Alzheimer's disease and their relation to functional impairment.
    Haxby JV; Rapoport SI
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):427-38. PubMed ID: 3541045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data.
    Azari NP; Pettigrew KD; Schapiro MB; Haxby JV; Grady CL; Pietrini P; Salerno JA; Heston LL; Rapoport SI; Horwitz B
    J Cereb Blood Flow Metab; 1993 May; 13(3):438-47. PubMed ID: 8478402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET.
    Pietrini P; Alexander GE; Furey ML; Dani A; Mentis MJ; Horwitz B; Guazzelli M; Shapiro MB; Rapoport SI
    J Nucl Med; 2000 Apr; 41(4):575-83. PubMed ID: 10768555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease.
    Haxby JV; Duara R; Grady CL; Cutler NR; Rapoport SI
    J Cereb Blood Flow Metab; 1985 Jun; 5(2):193-200. PubMed ID: 3988821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease.
    Bokde AL; Pietrini P; Ibáñez V; Furey ML; Alexander GE; Graff-Radford NR; Rapoport SI; Schapiro MB; Horwitz B
    Arch Neurol; 2001 Mar; 58(3):480-6. PubMed ID: 11255453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional brain imaging in the resting state and during activation in Alzheimer's disease. Implications for disease mechanisms involving oxidative phosphorylation.
    Rapoport SI
    Ann N Y Acad Sci; 1999; 893():138-53. PubMed ID: 10672235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of Alzheimer's disease with PET.
    Salmon E; Sadzot B; Maquet P; Degueldre C; Lemaire C; Rigo P; Comar D; Franck G
    J Nucl Med; 1994 Mar; 35(3):391-8. PubMed ID: 8113882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type.
    Haxby JV; Grady CL; Koss E; Horwitz B; Heston L; Schapiro M; Friedland RP; Rapoport SI
    Arch Neurol; 1990 Jul; 47(7):753-60. PubMed ID: 2357155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project.
    Morbelli S; Perneczky R; Drzezga A; Frisoni GB; Caroli A; van Berckel BN; Ossenkoppele R; Guedj E; Didic M; Brugnolo A; Naseri M; Sambuceti G; Pagani M; Nobili F
    J Nucl Med; 2013 Jun; 54(6):894-902. PubMed ID: 23591639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's disease.
    Rapoport SI
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():46-55. PubMed ID: 10654100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution PET studies in Alzheimer's disease.
    Kumar A; Schapiro MB; Grady C; Haxby JV; Wagner E; Salerno JA; Friedland RP; Rapoport SI
    Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.